IndraLab

Statements


STAMBP activates LUAD tumor metastasis. 1 / 1
| 1

eidos
"Our findings that STAMBP knockdown promotes EGFR degradation and suppresses LUAD tumor metastasis raise the possibility that targeting STAMBP may be a promising strategy to control LUAD progression ."